Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1287-1292
Published online before print March 10, 2005, doi: 10.1161/01.ATV.0000161927.38739.6f
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
25/6/1287    most recent
01.ATV.0000161927.38739.6fv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Soria, J. M.
Right arrow Articles by Fontcuberta, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Soria, J. M.
Right arrow Articles by Fontcuberta, J.
Related Collections
Right arrowRelated Article
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25:1287.)
© 2005 American Heart Association, Inc.


Thrombosis

A Genome Search for Genetic Determinants That Influence Plasma Fibrinogen Levels

José Manuel Soria; Laura Almasy; Juan Carlos Souto; Alfonso Buil; Mark Lathrop; John Blangero; Jordi Fontcuberta

From the Unitat d’Hemostàsia i Trombosi (J.M.S., J.C.S., A.B., J.F.), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; Southwest Foundation for Biomedical Research (L.A., J.B.), San Antonio, Tex; and Centre National de Genotypage (M.L.), Evry, France.

Correspondence to Dr José Manuel Soria, Unitat d’Hemostàsia i Trombosi, Hospital de la Santa Creu i Sant Pau, C/Sant Antoni M Claret 167, 08025, Barcelona, Spain. E-mail jsoria{at}hsp.santpau.es

Background— Fibrinogen levels are a widely accepted risk factor for cardiovascular disease, but the extent of the genetic component is unknown.

Materials and Results— To search for these genes, we conducted a genome-wide scan using 21 Spanish families from the Genetic Analysis of Idiopathic Thrombophila (GAIT) Project. Two loci were detected: 1 on chromosome 12 and another on chromosome 14. There are no cardiovascular-related candidate genes on chromosome 14, which implies that this locus represents a novel cardiovascular risk factor. Importantly, the locus on chromosome 12 contains the hepatocyte nuclear factors (TCF1), a candidate gene involved in the hepatocyte-specific transcription of the fibrinogen {alpha}-chain and ß-chain genes. Three polymorphisms in TCF1 showed significant association with fibrinogen levels, supporting the implication of TCF1 in the determination of this phenotype.

Conclusions— Two loci, 1 on chromosome 12 (most likely the TCF1) and another on chromosome 14, are important determinants of fibrinogen levels in Spanish families. These data should help define the relationship between fibrinogen levels and the risk of cardiovascular disease.

Fibrinogen level is a risk factor for cardiovascular disease, but most of the genetic components are unknown. In a genome-wide linkage scan, 2 loci were detected: 1 on chromosome 12 (most likely the TCF1) and another on chromosome 14, which are important determinants of fibrinogen levels in Spanish families.


Key Words: thrombosis • quantitative trait locus • GAIT Project • fibrinogen and TCF1 gene


Related Article:

Quest for Genes Regulating Plasma Fibrinogen Concentration: Still a Long Way to Go
Anders Hamsten, Maria Nastase Mannila, and Angela Silveira
Arterioscler. Thromb. Vasc. Biol. 2005 25: 1100-1101. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
BloodHome page
S. Uitte de Willige, M. C. H. de Visser, J. J. Houwing-Duistermaat, F. R. Rosendaal, H. L. Vos, and R. M. Bertina
Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen {gamma}' levels
Blood, December 15, 2005; 106(13): 4176 - 4183.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Hamsten, M. N. Mannila, and A. Silveira
Quest for Genes Regulating Plasma Fibrinogen Concentration: Still a Long Way to Go
Arterioscler. Thromb. Vasc. Biol., June 1, 2005; 25(6): 1100 - 1101.
[Full Text] [PDF]